From dermatology and aesthetics to surgery and ophthalmology, our energy-based platforms are purpose-built for specific clinical workflows — not adapted from general-purpose hardware.
Our CO2 and non-ablative fractional platforms address the full spectrum of skin concerns, from fine lines and wrinkles to severe scarring. The UltraPulse system's SCAAR FX technology reaches depths of up to 4mm in the reticular dermis, creating columns of thermal damage that trigger neocollagenesis without the prolonged downtime of fully ablative treatment.
Limitation note: Fractional CO2 resurfacing carries a documented risk of post-inflammatory hyperpigmentation, particularly in Fitzpatrick skin types IV-VI. Conservative parameter selection and extended pre/post-treatment protocols are recommended for these populations. Individual outcomes vary based on patient factors.
Request Clinical Data
The LightSheer platform uses 805nm diode laser energy with a proprietary vacuum-assist mechanism that reduces required fluence by approximately 50%, allowing faster treatment of large body areas with reduced patient discomfort. The high-speed handpiece treats a full back in approximately 15 minutes — compared to 45+ minutes for conventional systems, based on internal comparative timing data.
Note: "Permanent hair removal" in the laser context means permanent hair reduction per FDA terminology. Multiple sessions are required, and some regrowth may occur over time, especially in hormonally influenced areas.
Learn About LightSheer
The M22 platform combines IPL (Optimal Pulse Technology) with dedicated Nd:YAG and ResurFX modules. Interchangeable filters from 515nm to 1064nm allow practitioners to target oxyhemoglobin, melanin, and water chromophores selectively. Over 30 FDA-cleared indications cover the range from rosacea and telangiectasia to sun damage and acne.
Lumenis surgical laser platforms serve urology, ENT, gynecology, and general surgery with holmium (Ho:YAG) and CO2 wavelengths. The MOSES technology for holmium lithotripsy was developed through collaboration with practicing urologists and demonstrates improved stone fragmentation efficiency compared to conventional holmium delivery in published controlled studies.
Our clinical technology specialists will analyze your practice requirements, patient demographics, and workflow to recommend the appropriate Lumenis configuration.
Schedule a Consultation